![Kelly Chow](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Kelly Chow
Sociétés | Poste | Début | Fin |
---|---|---|---|
Belharra Therapeutics, Inc.
![]() Belharra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Belharra Therapeutics, Inc. is a drug discovery company that utilizes a unique photoaffinity-based chemoproteomics platform to identify novel small molecule drug candidates for previously difficult-to-treat diseases and conditions. The company is based in San Diego, CA, with its primary lab and offices located in the area. Belharra's proprietary discovery engine allows for the identification of small molecule starting points for drug development on any protein, in any conformational state, and in any cell type. The company was founded in 2021 by John Teijaro, Christopher G. Parker, Stuart L. Schreiber, and Benjamin F. Cravatt, and has since been led by CEO Jeffrey Jonker. | Directeur des opérations | 01/01/2022 | - |
Historique de carrière de Kelly Chow
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Chief Operating Officer | 1 |
Sectorielle
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Belharra Therapeutics, Inc.
![]() Belharra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Belharra Therapeutics, Inc. is a drug discovery company that utilizes a unique photoaffinity-based chemoproteomics platform to identify novel small molecule drug candidates for previously difficult-to-treat diseases and conditions. The company is based in San Diego, CA, with its primary lab and offices located in the area. Belharra's proprietary discovery engine allows for the identification of small molecule starting points for drug development on any protein, in any conformational state, and in any cell type. The company was founded in 2021 by John Teijaro, Christopher G. Parker, Stuart L. Schreiber, and Benjamin F. Cravatt, and has since been led by CEO Jeffrey Jonker. | Health Services |
- Bourse
- Insiders
- Kelly Chow
- Expérience